DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

company name or ticker
Company Photos
(Click to zoom)

Could the Next Generation of Diabetes Treatments Be Found in This Illegal Drug?

Diabetes affects more than 29 million Americans and can lead to a number of serious complications. However, this currently illegal drug could provide a new pathway for diabetics to achieve better glycemic balance.

Exciting News: A Game-Changing Shingles Vaccine Could Be On Its Way

GlaxoSmithKline plc has reported impressive late stage trial results for its shingles vaccine.

Zoetis: Betting The Proverbial Farm?

Merck Up on OncoEthix Acquisition Deal, Oncology in Focus - Analyst Blog

Tetraphase Spikes on Encouraging Data on Antibiotic - Analyst Blog

Merrill Lynch Top Healthcare Stock Picks for 2015

NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst Blog

Battle In Hepatitis C Market: Bristol-Myers Squibb Needs To Speed Up

MRK Crosses Above Key Moving Average Level

2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses

See More Articles...